Prognostic significance of serum level of vascular endothelial growth factor receptor-2 in hepatocellular carcinoma patients after transcatheter arterial chemoembolization

National Medical Journal of China

Volumn 93, Issue 5, 2013, Pages 341-344

  Meng, Qing Wen ^a   Li, Yong ^a   Hu, Bao Shan ^a   Shao, Pei Jian ^a   Zhan, Mei Xiao ^a   Yu, Xian Yi ^a   Lu, Li Gong ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Carcinoma, hepatocellular; Drug therapy, combination; Vascular endothelial growth factor receptor 2

Indexed keywords

VASCULOTROPIN RECEPTOR 2;

ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL FEATURE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; PROTEIN BLOOD LEVEL;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84874375402     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2013.05.005     Document Type: Article

References (15)

1. Li Q, Dong X, Gu W, et al. Clinical significance of co-expression of VEGF-C and VEGFR-3 in non-small cell lung cancer. Chin Med J (Engl), 2003, 116: 727-730.
2. Iavarone M, Lampertico P, Iannuzzi F, et al. Increased expression of vascular endothelial growth factor in small hepatocellular carcinoma. J Viral Hepat, 2007, 14: 133-139.
3. Amaoka N, Saio M, Nonaka K, et al. Expression of vascular endothelial growth factor receptors is closely related to the histological grade of hepatocellular carcinoma. Oncol Rep, 2006, 16: 3-10.
4. Aucejo F, Kim R, Zein N, et al. Vascular endothelial growth factor receptor 2 expression in non-tumorous cirrhotic liver is higher when hepatoma is beyond Milan criteria. Liver Transpl, 2009, 15: 169-176.
5. Jia J B, Zhuang P Y, Sun H C, et al. Protein expression profiling of vascular endothelial growth factor and its receptors identifies subclasses of hepatocellular carcinoma and predicts survival. J Cancer Res Clin Oncol, 2009, 135: 847-854.
6. Dayanir V, Meyer R D, Lashkari K, et al. Identification of tyrosine residues in vascular endothelial growth factor receptor-2/ FLK-1 involved in activation of phosphatidylinositol 3-kinase and cell proliferation. J Biol Chem, 2001, 276: 17686-17692.
7. 2010, 90: 3014-3018.
8. Dineen S P, Lynn K D, Holloway S E, et al. Vascular endothelial growth factor receptor 2 mediates macrophage infiltration into orthotopic pancreatic tumors in mice. Cancer Res, 2008, 68: 4340-4346.
9. Korpanty G, Carbon J G, Grayburn P A, et al. Monitoring response to anticancer therapy by targeting microbubbles to tumor vasculature. Clin Cancer Res, 2007, 13: 323-330.
10. Nakamura K, Zen Y, Sato Y, et al. Vascular endothelial growth factor, its receptor Flk-1, and hypoxia inducible factor-1 alpha are involved in malignant transformation in dysplastic nodules of the liver. Hum Pathol, 2007, 38: 1532-1546.
11. Karkkainen M J, Petrova T V. Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis. Oncogene, 2000, 19: 5598-5605.
12. 2003, 37: 1078-1082.
13. 2005, 39: 204-205.
14. Jia L, Kiryu S, Watadani T, et al. Prognosis of hepatocellular carcinoma with portal vein tumor thrombus: assessment based on clinical and computer tomography characteristics. Acta Med Okayama, 2012, 66: 131-141.
15. Shan B, Gao C, Chen J M, et al. Establishment of a sandwich ELISA method for detection of vascular endothelial growth factor in serum samples of hepatocellular carcinoma patients. Biomed Environ Sci, 2008, 21: 69-74.